Key Takeaways
- Revenue declined, margins improved: Standalone revenue fell QoQ to ₹233.73 cr, the third straight quarter of decline, while gross margin expanded 246 bps QoQ and EBITDA margin grew 136 bps QoQ on calibrated pricing and softer raw materials.
- Raw material volatility drove extreme caution: Falling input prices led the company and its customers to slash inventory holding, with Rossari choosing to forego sales rather than risk buying into a declining market.
- Acquired companies delivered: Unitop, Tristar, and Romakk Chemicals posted improved or strong growth, with Unitop’s agro surfactants business recording a historically robust Q1.
- FY23 guidance held, but H2-dependent: Management maintained its ₹250 cr EBITDA and ₹150 cr PAT target, while flagging that Q2 will look similar to Q1 and the improvement must come from H2.
- What to watch next quarter: Whether the H2 recovery narrative holds once Q2 prints, the pace of raw material stabilization, and any concrete margin lift toward the 14–15% medium-term target.
Revenue Headwinds & Demand Environment
- Standalone decline across all segments: HPPC, TSC, and AHN all fell sequentially; HPPC standalone dropped from ₹126 cr in Q1 FY22 to ₹115 cr in Q1 FY23, driven primarily by pricing as key raw material costs fell.
- Inventory destocking amplified the slowdown: Falling raw material prices made customers buy for only 10–15 days instead of a month, while Rossari itself held back from purchasing to avoid being caught with high-cost stock.
- Textile demand subdued but a big customer win cushioned the blow: North American and European textile uptake stayed weak because of the Ukraine war and high US inventories, yet Rossari landed a substantial new textile customer that helped sustain revenues.
- HPPC grammage disruption: A major brand changed product grammage three times in two to three months, disrupting supply chains, ERP systems, and distributor networks, with grammage reductions shrinking business volume.
- Sanitizer sales collapsed, disinfectants picked up: Sanitizer sales are now roughly 10% or less of earlier levels as the general public stopped using it; offset partially by increased disinfectant sales with a large FMCG major.
- Paint business at seasonal trough: Monsoon is always the weakest quarter for paint, and weekly falling butyl acrylic prices meant Rossari chose not to step in and buy raw material.
- Q2 FY22 base effect warning: Management cautioned against comparing Q2 FY23 to Q2 FY22, which was an abnormal quarter when competitors lacked raw material and Rossari supplied from its stocked inventory.
Chari: "We are also very cautious in terms of not entering into segments or not buying raw materials, it is better to forego sales, rather than set up sorry figure."
Margin Dynamics & Profitability
- Gross margin up 246 bps QoQ: Driven by calibrated price increases, efficient working capital management, and softening raw material prices.
- HPPC margin mechanics compressed percentages but protected absolute profit: When selling at ₹100 earning 15% margin (₹15), price increases led customers to demand the same ₹15 absolute margin on a higher base, so percentages fell while absolute rupees stayed intact.
- Investment spending held despite margin pressure: ~₹2 cr spent on eight exhibitions in the US and India, plus ₹1 cr on Tristar’s phenoxy propanol Reach Registration; without these, EBITDA margin would have been 15% in Q1.
- Textile profitability improved sharply: Gross margins in the textile business improved by more than 300 basis points, which management called very heartening.
- Purchase of stock in trade: ~₹18 cr in Q1; in a falling raw material scenario, selling off raw material at no profit made sense because holding it would incur losses the next month.
- Inventory valuation change had no material impact: The switch from FIFO to Weighted Average Cost method in Q1 did not materially affect financial numbers.
Sablok: "Given the current situation, I think question on steady state, our immediate medium-term target is to come back to our 14% - 15% kind of EBITDA margin and on a longer-term basis, I think we keep regiving our product portfolio. We aim to be 15% to 17% plus margin over the next year or two."
Acquired Companies: Unitop, Tristar & Romakk
- Unitop delivered a historically strong Q1: Agro surfactant sales were very robust because Q1 is seasonally the biggest quarter, with rains starting in north India from June-end/July.
- Tristar sales were good, EO availability improving: Better availability of ethylene oxide was seen from July onward, supporting the business.
- Raw material pressure easing at both units: Pressure on raw material prices is going down in Unitop and Tristar.
- Unitop FY23 turnover expected at ₹450–500 cr: Q1 contributed roughly one-third, with the balance two-thirds spread over the next three quarters.
- Joint development bearing fruit across group companies: Over the last two to three quarters, cross-company R&D yielded in-house silicone oils for textile and agro, a super spreader from ethoxylate reacted with silicones, phenoxy propanol developed jointly between Unitop and Tristar, and new esters produced at Rossari and consumed at Unitop.
- First payment for additional Unitop stake due: The first tranche for 15% more shares of Unitop was payable on August 28.
New Product Pipeline & Innovation
- Textile technology expansion: New products include spin finishes for textiles, acrylic coating chemicals and single-pack polyurethane coating for technical textiles, and polyester-based and acrylic-based sizing agents targeting export markets.
- Sustainable black dyeing gaining traction: The process is picking up fast in the marketplace.
- Green series expanding: New products under development include one for exhaustion of dyes and an enzyme-based scouring product using fusion chemistry between enzymes and chemicals, alongside existing green acid, green soda, and green hydro.
- Paint market entry: Introduced xylene-based binders enabling easy stain release, easy cleaning, and no static attraction for less dust extraction.
- Animal health, nutrition, and pet food: Esters and glycerides are at the final stage of testing and will be introduced shortly; pet food introduction is finalized for the coming quarter.
- European footprint expansion underway: Efforts to expand in Europe for new agro and preservative products.
- HPPC customer base still under-penetrated: Rossari is not present in even a quarter of the addressable customer base by number of customers; added new HPPC customers last quarter and more than five to six in July alone.
Strategy & Capital Allocation Philosophy
- Absolute EBITDA over percentage margins: Management’s stated focus is on the absolute amount of money earned and on asset turns, arguing that an asset turnover of 5 with 13% EBITDA is better than 25% EBITDA with an asset turnover of 1.
- Agro as a margin lever at consolidated level: As agro sales grow over the next two to five years, with outreach to customers in Europe and the US, the absolute percentage at the consolidated level is expected to improve.
- Raw material stabilization is the unlock for margin percentage: Once the raw material situation improves over the next year or so, management believes it can take a better look at how to improve margin percentage.
Chari: "As a company now our focus will be on absolute amount of money, we would not look at percentage of EBITDA. Secondly, our focus would be on asset turns."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| FY23 EBITDA and PAT | ₹250 cr EBITDA, ₹150 cr PAT; may revisit after Q2 | FY23, with Q2 review point |
| Q2 FY23 revenue | Similar to Q1 FY23 levels (not vs abnormal Q2 FY22) | Q2 FY23 |
| H2 improvement | Numbers anticipated to improve from H2 onward | H2 FY23 |
| Unitop FY23 turnover | At least ₹450–500 cr | FY23 |
| Medium-term EBITDA margin | Return to 14–15% | Medium-term |
| Longer-term EBITDA margin | 15–17%+ (internal target) | Next year or two |
| Paint business Q2 | Higher sales expected vs Q1 | Q2 FY23 |
| Pet food introduction | Finalized for launch | Coming quarter |
| Animal health esters and glycerides | Final stage of testing, introduction shortly | Near-term |
Key Metrics
| Metric | Q1 FY23 |
|---|---|
| Consolidated revenue from operations | ₹434.7 crore, vs ₹438.9 crore in Q4 FY22 |
| Standalone revenue from operations | ₹233.73 crore, vs ₹261.64 crore in Q4 FY22; +15% YoY |
| HPPC revenue | ₹316.5 crore, 73% of total revenue |
| Textile business revenue | ₹93.9 crore, 21% of total revenue |
| AHN revenue | ₹24.3 crore, 6% of total revenue |
| Consolidated EBITDA | ₹57.7 crore, vs ₹52.3 crore in Q4 FY22 |
| Consolidated EBITDA margin | 13.3%, vs 11.9% in Q4 FY22 |
| Consolidated PAT | ₹28.7 crore, vs ₹24.1 crore in Q4 FY22 |
| Standalone EBITDA | ₹27.1 crore, vs ₹27.5 crore in Q4 FY22 |
| Standalone EBITDA margin | 11.6%, vs 10.5% in Q4 FY22 |
| Standalone PAT | ₹15.4 crore, vs ₹16.9 crore in Q4 FY22 |
| Gross margin QoQ change | +246 bps |
| EBITDA QoQ change | +136 bps |
| Depreciation | ₹15.3 crore, higher owing to amortization of fair valuation on consolidation of subsidiaries |
| Interest costs | ₹5.1 crore |
| Unitop Q1 FY23 revenue | ~₹150 crore, out of ~₹200 crore revenue difference between standalone and consolidated |
| Unitop expected FY23 turnover | at least ₹450–500 crore |
| FY23 EBITDA guidance | ₹250 crore (reiterated) |
| FY23 PAT guidance | ₹150 crore (reiterated) |
| Standalone HPPC QoQ growth | 8% degrowth QoQ, 10% growth over Q1 FY22 |
| Textile business gross margin improvement | more than 300 bps |
| Medium-term EBITDA margin target | 14% to 15% |
| Longer-term internal EBITDA margin target | 15% to 17% plus, over next year or two |
| Unitop Agro share of Unitop sales | 60% to 65% |
| Sanitizer sales vs prior levels | ~10% or less of earlier sales |
| Exhibition spend in Q1 | ~₹2 crore |
| Tristar phenoxy propanol Reach Registration spend | ₹1 crore |
| Consolidated purchase of stock in trade | ~₹18 crore |